Simaya AI
Simaya AI9
About
What does Simaya AI do?
Simaya AI provides patient drug prediction by modeling the biology behind drug responses to estimate who a drug is most likely to help before clinical trials begin. Their platform serves pharma and biotech R&D teams by offering per-patient predictions for treatment response, toxicity, and optimal dosage, enabling more precise patient selection for clinical trials. This approach reasons from biology, not just correlation, to provide mechanistic, inspectable reasons for each prediction.
Where is Simaya AI headquartered?
Simaya AI is headquartered in גת (קיבוץ), Israel.
When was Simaya AI founded?
Simaya AI was founded in 2026.
What industry does Simaya AI operate in?
Simaya AI operates in Biotech, Drug Discovery, Clinical Trials, AI-Driven Drug Discovery, Precision Medicine, Genomics.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.